RWHAP Part A Manual
Manual for Ryan White Part A recipients and planning bodies on administration of their programs.
Resource updated 09/19/2023
Manual for Ryan White Part A recipients and planning bodies on administration of their programs.
Resource updated 09/19/2023
View and download slides from sessions in this 2018 National Ryan White Conference track — Ryan White HIV/AIDS Program Fiscal and Grant Management Boot Camp.
Resource updated 09/14/2023
View and download presentation slides from the 2018 National Ryan White Conference on HIV Care and Treatment. See the links below to the six tracks and 250 sessions.
Resource updated 09/14/2023
Resource updated 05/08/2024
Performance measures to help Ryan White HIV/AIDS Program agencies monitor and improve the quality of care they deliver.
Resource updated 09/19/2023
The 2020 Ryan White National Conference (RWNC) featured one plenary a day. Each plenary had a topical focus and multiple speakers ranging from Federal officials, community partners, recipients, and people living with and affected by HIV.
Resource updated 04/18/2024
Series of webinars for Ryan White HIV/AIDS Program (RWHAP) agencies, by HRSA's HIV/AIDS Bureau.
Resource updated 03/07/2024
Webinars and other special events by HRSA's HIV/AIDS Bureau.
Resource updated 01/09/2024
The AIDS Institute will present its analysis of RWHAP funding for the Ending the HIV Epidemic states and jurisdictions in the context of resource allocation to meet the initiative goals and ensure the success of ending the epidemic. Additionally, presenters representing a local jurisdiction will provide their planning and operational experience through the initiative.
Resource (Conference Presentation) updated 09/14/2023
In a multi-site community health center system, the most challenging patients with HIV and hepatitis C (HCV) co-infection were assessed for HICV cure, and the solutions developed to overcome their barriers to treatment were translated into systems change. The presenters will discuss the challenges, solutions, and resultant system changes.
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Through the Southern Initiative, CAI supported four Part A agencies in the South in integrating a Community Health Worker (CHW) model to address disparities in HIV outcomes. The session will describe the development of systems to collect, report, and use real-time data to track implementation progress and client outcomes. Results reveal promising client outcomes.
Resource (Conference Presentation) updated 09/14/2023
As HIV elimination activities increase, jurisdictions can address HIV/Hepatitis C (HCV) co-infection by enhancing HCV screening and treatment data collection. This session will discuss NASTAD's work with North Carolina to incorporate HCV data in CAREWare and electronic health records (EHRs), as well as recommendations for integrating HCV services into the HIV care infrastructure.
Resource (Conference Presentation) updated 09/14/2023
Successes and lessons learned will be shared from three metropolitan areas on incorporating STI testing and treatment for prevention clients within an HIV medical home setting, along with how offering STI treatment impacts early identification service outcomes (e.g., HIV positivity rates, linkage to care referrals, and the rapid start of HIV treatment).
Resource (Conference Presentation) updated 09/14/2023
Learn how to develop, plan, and implement an organization-wide ECHO model to fully integrate HIV/HCV care and treatment into primary care centers and create wider access for patients with less barriers to care.
Resource (Conference Presentation) updated 09/14/2023
This interactive workshop will review updated data and discuss implementation challenges, facilitators, and best practices for routine screening/linkage in an emergency department with urban and rural challenges. Preliminary data from the initial two months (with more than 2,000 patients screened) include .7% HIV (including three acute infections), 7% Hepatitis C (HCV) and 5.2% syphilis.
Resource (Conference Presentation) updated 09/14/2023
This workshop will present findings from three recently completed HRSA/HAB-sponsored studies that evaluated the impact of the RWHAP, specifically regarding its cost-effectiveness, models of clinical care, and factors associated with viral suppression.
Resource (Conference Presentation) updated 09/14/2023